1. Home
  2. LION vs BEAM Comparison

LION vs BEAM Comparison

Compare LION & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LION
  • BEAM
  • Stock Information
  • Founded
  • LION 1997
  • BEAM 2017
  • Country
  • LION United States
  • BEAM United States
  • Employees
  • LION N/A
  • BEAM N/A
  • Industry
  • LION Movies/Entertainment
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LION Consumer Discretionary
  • BEAM Health Care
  • Exchange
  • LION Nasdaq
  • BEAM Nasdaq
  • Market Cap
  • LION 1.6B
  • BEAM 1.9B
  • IPO Year
  • LION N/A
  • BEAM 2020
  • Fundamental
  • Price
  • LION $6.85
  • BEAM $19.45
  • Analyst Decision
  • LION Strong Buy
  • BEAM Strong Buy
  • Analyst Count
  • LION 6
  • BEAM 11
  • Target Price
  • LION $9.58
  • BEAM $48.90
  • AVG Volume (30 Days)
  • LION 2.5M
  • BEAM 2.4M
  • Earning Date
  • LION 08-07-2025
  • BEAM 08-05-2025
  • Dividend Yield
  • LION N/A
  • BEAM N/A
  • EPS Growth
  • LION N/A
  • BEAM N/A
  • EPS
  • LION N/A
  • BEAM N/A
  • Revenue
  • LION $3,947,900,000.00
  • BEAM $63,578,000.00
  • Revenue This Year
  • LION N/A
  • BEAM N/A
  • Revenue Next Year
  • LION $7.02
  • BEAM $17.18
  • P/E Ratio
  • LION N/A
  • BEAM N/A
  • Revenue Growth
  • LION N/A
  • BEAM N/A
  • 52 Week Low
  • LION $5.55
  • BEAM $13.53
  • 52 Week High
  • LION $8.50
  • BEAM $35.25
  • Technical
  • Relative Strength Index (RSI)
  • LION 58.91
  • BEAM 63.94
  • Support Level
  • LION $5.64
  • BEAM $20.75
  • Resistance Level
  • LION $7.00
  • BEAM $22.51
  • Average True Range (ATR)
  • LION 0.28
  • BEAM 1.18
  • MACD
  • LION 0.15
  • BEAM 0.35
  • Stochastic Oscillator
  • LION 78.69
  • BEAM 74.58

About LION Lionsgate Studios Corp. Common Shares

Lionsgate Studios Corp is a company encompasses world-class motion picture and television studio operations and the STARZ-branded premium global subscription platforms to bring a unique and varied portfolio of entertainment to consumers around the world. The Studio Business consists of the Motion Picture and Television Production reportable segments, together with substantially all of Lionsgate's corporate general and administrative costs. Motion Picture consists of the development and production of feature films, acquisition of North American and worldwide distribution rights. Television Production consists of the development, production and worldwide distribution of television productions including television series, television movies and mini-series, and non-fiction programming.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: